Apr 21, 2021

DMC and Conagen Partner for Commercial Manufacturing of L-alanine

21 April 2021 – DMC Biotechnologies and Conagen Inc. have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine.

L-alanine is a naturally occurring amino acid used widely in homecare products, human nutrition, and pharmaceutical applications. DMC’s fermentation technology enables L-alanine to be produced with attractive economics as part of a regional supply chain with increased reliability and greater sustainability.

This partnership combines Conagen’s production expertise with DMC’s bioprocess technology and follows DMC’s demonstration of commercial-scale production (85m3) in March 2021. DMC has a robust product pipeline, including additional amino acids, that will subsequently be brought to the market.

Matt Lipscomb, Ph.D., CEO & Co-Founder of DMC said, “We have successfully advanced our first product, L-alanine toward commercialization in less time and with much less capital than has traditionally been required in the biotech industry. DMC is now in a position to meet growing customer needs for economically attractive and sustainably produced products. The pandemic has clearly shown the value of regional and robust supply chains for everyday products.”

“We are proud to collaborate with DMC as a manufacturing partner to bring L-alanine to the growing global market. Utilizing our well-established R&D and commercialization capabilities, we are honored to provide commercial-scale production of DMC’s first product meeting customer requirements,” said Conagen CEO Oliver Yu.

DMC media contact:
Kathryn Sheridan
Sustainability Consult
[email protected] 

Conagen media contact:
Ana Arakelian
[email protected]

About DMC
DMC is a US biobased chemical company that makes products using microbial fermentation. Their proprietary technology simplifies biology and makes fermentation more predictable, robust, and efficient. DMC is on track to address two of the global challenges of our time: sustainably and affordably feeding a growing world population and reducing greenhouse gas emissions through efficient production of (bio)chemicals. For more information, visit: www.dmcbio.com

About Conagen
Conagen is making the impossible possible. Our scientists and engineers use the latest synthetic biology tools to develop sustainable, nature-based molecules bio-manufactured into the highest quality products available. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. For more information, visit www.conagen.com

Other NEWS

DMC & Duke Receive NSF STTR Phase 1 Award

DMC & Duke Receive NSF STTR Phase 1 Award

STTR Phase I: Commercialization of Synthetic Metabolic Valves Award Information Agency: National Science Foundation Branch: N/A Contract: 1549624 Agency Tracking Number: 1549624 Amount: $225,000.00 Phase: Phase I Program: STTR Solicitation Topic Code: BT Solicitation...

read more
DMC & Duke Receive NSF STTR Phase 1 Award

DMC & Duke Receive NSF STTR Phase 1B Award

Award Abstract #1549624 STTR Phase I: Commercialization of Synthetic Metabolic Valves NSF Org: IIP Div Of Industrial Innovation & Partnersh Initial Amendment Date: December 18, 2015 Latest Amendment Date: December 23, 2016 Award Number: 1549624 Award Instrument:...

read more
DMC & Duke Receive NSF STTR Phase 1 Award

Duke and DMC Receive DOE Award for Innovative Bioenergy R&D

DOE Announces $10 Million for Innovative Bioenergy Research and Development The U.S. Department of Energy announced up to $10 million in funding for six projects representing innovative technologies and solutions to advance bioenergy development. These projects,...

read more